From Professor Poulam Patel, Head of Division:
We aim to develop new treatments to target cancer by focusing at the interface between laboratory and clinical research. Our efforts concentrate on better understanding of the tumour microenvironment, by not only studying cancers themselves but importantly the interactions between the tumour and the body.
We carry out phase I, II and III trials, working with other academic institutions and the pharmaceutical industry, in local, national and international trials. We have a national and international profile in several cancer types including melanoma, renal cancer, breast, gynaecological and upper gastro-intestinal cancers. Our stem cell biology group model a wider range of diseases and mechanisms. In all cases, the close collaboration between laboratory and clinic promote exchange of both ideas and clinical material to facilitate more effective cancer research.